Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
10/8/2024
Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...
10/8/2024
Zephyrm Bioscience Files for IPO on HKSE with CICC as Sponsor
10/8/2024
Genor Biopharma to Merge with Eddingpharm in Strategic Reverse Takeove...
10/8/2024
Innovent and Ask Pharm Enter Strategic Deal for Limertinib
10/8/2024
AstraZeneca gains rights to CSPC's lipid-lowering therapy in deal wort...
10/8/2024
MediLink and Amgen Enter Global Clinical Trial Deal on YL201 Combinat...
10/3/2024
Domestic Pharma Companies Saw Rapid Growth in Outlicensing Deals in 20...
10/3/2024
WuXi Considers Asset Sales Amid BIOSECURE Scrutiny: FT
10/1/2024
AFT in China License Deal with Xizang Weixinkang Pharma for Maxigesic ...
10/1/2024
Haleon Plans to Raise Stake in Chinese JV to 88%
10/1/2024
Akeso's Cadonilimab Receives Second Indication Approval from NMPA
10/1/2024
Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China
10/1/2024
Genentech to Acquire Regor Pharma’ Next-Generation CDK Inhibitor Port...
10/1/2024
Alphamab and CSPC Enter a Licensing Deal on Anti-HER2 BsADC JSKN003 in...
10/1/2024
HUTCHMED Announces Japan Approval for FRUZAQLA (fruquintinib) Received...
10/1/2024
Kailera Secures $400M Series A Funding to Develop Obesity and Diabetes...
9/27/2024
Jixing Pharma Secures $2.75M in Series D+ Financing from Apeloa Hong K...
9/27/2024
Ribo and Pheiron Enter Strategic Deal for AI-assisted Drug Development...
9/27/2024
TJ Biopharma Secures €213M Deal with Sanofi for Greater China Rights ...
9/27/2024
China Rises as a Major Player in Oncology with ADCs Boom: GlobalData
9/27/2024
Daehwa Pharm's Liporaxel Gains Chinese Approval to Treat Gastric Cance...
9/26/2024
Bayer Opens First Co.Lab in China in Shanghai
9/24/2024
LongBio Secures CNY 100M in Series B2 Financing to Advance Antibody Th...
9/23/2024
AstraZeneca Korea Launches Open Innovation Program to Support Korean B...
9/20/2024
Ocumension Therapeutics's ZERVIATE Approved in China
9/19/2024
Kenvue Targets Innovation to Capitalize on China's Expanding Consumer ...
9/19/2024
Kite Sells Stake in Fosun JV, Giving Chinese Partner Full Control of C...
9/19/2024
Celregen Thera Secures CNY Multi-Millions in Angel Round Financing
9/18/2024
China to Accelerate Approval of Innovative Drugs and Medical Devices, ...
9/13/2024
China Courts Global Pharma with Promises of Faster Drug Approvals and ...
Page:
14
/
21
Total number of articles:
605
:
[First]
[<<]
[12]
[13]
[14]
[15]
[16]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit